Antileishmanial Activity of a Series of N2,N4-Disubstituted Quinazoline-2,4-diamines
Citations Over TimeTop 10% of 2014 papers
Abstract
A series of N(2),N(4)-disubstituted quinazoline-2,4-diamines has been synthesized and tested against Leishmania donovani and L. amazonensis intracellular amastigotes. A structure-activity and structure-property relationship study was conducted in part using the Topliss operational scheme to identify new lead compounds. This study led to the identification of quinazolines with EC50 values in the single digit micromolar or high nanomolar range in addition to favorable physicochemical properties. Quinazoline 23 also displayed efficacy in a murine model of visceral leishmaniasis, reducing liver parasitemia by 37% when given by the intraperitoneal route at 15 mg kg(-1) day(-1) for 5 consecutive days. Their antileishmanial efficacy, ease of synthesis, and favorable physicochemical properties make the N(2),N(4)-disubstituted quinazoline-2,4-diamine compound series a suitable platform for future development of antileishmanial agents.
Related Papers
- → Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against Leishmania donovani(2020)33 cited
- → β-Nitrostyrenes as Potential Anti-leishmanial Agents(2016)26 cited
- → Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani(2015)15 cited
- → Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani(2016)38 cited
- CHARACTERIZATION OF HIGH ACTIVITY DRUG-STIMULATED ATPase OF MULTIDRUG RESISTANT LEISHMANIA DONOVANI AMASTIGOTE CELLS(2015)